| John Stephen Shank, MD | |
|
350 Fairview Heights Rd, Summersville, WV 26651 | |
| (304) 872-5090 | |
| (304) 872-0636 |
| Full Name | John Stephen Shank |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 54 Years |
| Location | 350 Fairview Heights Rd, Summersville, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306835152 | NPI | - | NPPES |
| 0055930000 | Medicaid | WV | |
| 550775750 | Other | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 11777 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summersville Regional Medical Center | Summersville, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia Health Care Cooperative Inc | 9830431030 | 45 |
News Archive
Predicting problems in one of the body's most complex organs soon may become easier because of work being done by Wayne State University researchers.
"Between 1970 and 2010, most emerging countries achieved impressive gains in contraceptive coverage," but, "[b]y contrast, many sub-Saharan African (SSA) countries ... have started their contraceptive revolution very late and progress to date has been minimal," John May, a visiting fellow at the Center for Global Development (CGD), and Jean-Pierre Guengant, researcher emeritus at the Research Institute for Development (IRD) in Marseille, France, write in CGD's "Global Health Policy" blog.
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.
ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.
› Verified 7 days ago
| Entity Name | West Virginia Health Care Cooperative Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417415324 PECOS PAC ID: 9830431030 Enrollment ID: O20190508000440 |
News Archive
Predicting problems in one of the body's most complex organs soon may become easier because of work being done by Wayne State University researchers.
"Between 1970 and 2010, most emerging countries achieved impressive gains in contraceptive coverage," but, "[b]y contrast, many sub-Saharan African (SSA) countries ... have started their contraceptive revolution very late and progress to date has been minimal," John May, a visiting fellow at the Center for Global Development (CGD), and Jean-Pierre Guengant, researcher emeritus at the Research Institute for Development (IRD) in Marseille, France, write in CGD's "Global Health Policy" blog.
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.
ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.
› Verified 7 days ago
| Entity Name | West Virginia Health Care Cooperative Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1043778319 PECOS PAC ID: 9830431030 Enrollment ID: O20190531001788 |
News Archive
Predicting problems in one of the body's most complex organs soon may become easier because of work being done by Wayne State University researchers.
"Between 1970 and 2010, most emerging countries achieved impressive gains in contraceptive coverage," but, "[b]y contrast, many sub-Saharan African (SSA) countries ... have started their contraceptive revolution very late and progress to date has been minimal," John May, a visiting fellow at the Center for Global Development (CGD), and Jean-Pierre Guengant, researcher emeritus at the Research Institute for Development (IRD) in Marseille, France, write in CGD's "Global Health Policy" blog.
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.
ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Stephen Shank, MD Po Box 1029, Summersville, WV 26651-0139 Ph: (304) 872-5090 | John Stephen Shank, MD 350 Fairview Heights Rd, Summersville, WV 26651 Ph: (304) 872-5090 |
News Archive
Predicting problems in one of the body's most complex organs soon may become easier because of work being done by Wayne State University researchers.
"Between 1970 and 2010, most emerging countries achieved impressive gains in contraceptive coverage," but, "[b]y contrast, many sub-Saharan African (SSA) countries ... have started their contraceptive revolution very late and progress to date has been minimal," John May, a visiting fellow at the Center for Global Development (CGD), and Jean-Pierre Guengant, researcher emeritus at the Research Institute for Development (IRD) in Marseille, France, write in CGD's "Global Health Policy" blog.
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.
ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.
› Verified 7 days ago
Robert Charles Stanley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 702 Professional Park Dr, Suite 100, Summersville, WV 26651 Phone: 304-872-2991 Fax: 304-872-6268 | |
Bruce Kevin Greenberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Fairview Heights Rd, Summersville, WV 26651 Phone: 304-872-5090 Fax: 304-872-0636 | |
Dr. Crischelle L Shank, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Fairview Heights Rd, Summersville, WV 26651 Phone: 304-842-5090 | |
Dr. Richard Stockton Trenbath, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Merchants Walk, Shopping Center, Summersville, WV 26651 Phone: 304-872-9455 Fax: 304-872-9456 | |
Kathy Hamon, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 Main St, Summersville, WV 26651 Phone: 304-872-1663 Fax: 304-872-1804 | |
Mark Lynwood Wantz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Fairview Heights Rd, Summersville, WV 26651 Phone: 304-872-5090 Fax: 304-872-0636 | |
Miraflor G Khorshad, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 415 Main St, Summersville, WV 26651 Phone: 304-872-5500 Fax: 304-872-5592 |